Clasificación en acciones
#8990
Inventiva S.A. is a biopharmaceutical firm currently in the clinical... Inventiva S.A. is a biopharmaceutical firm currently in the clinical development phase, specializing in creating orally administered small molecule treatments for conditions such as non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and various other ailments. Their primary drug candidate, Lanifibranor, has successfully concluded Phase IIb clinical trials for the management of NASH. Furthermore, the company is advancing Odiparcil, a compound that has finished Phase IIa clinical testing specifically for treating the MPS VI subtype. Beyond these, Inventiva maintains a development pipeline featuring several early-stage projects targeting oncology and other medical conditions. Strategic partnerships are in place with AbbVie to address autoimmune diseases, and with Boehringer Ingelheim International GmbH for innovating therapies for idiopathic pulmonary fibrosis. Established in 2011, Inventiva S.A. operates from its headquarters in Daix, France.
Precio por acción
$4.74
Última sincronización: 2026-08-28
Capitalización bursátil
$1.12B
Comercio Inventiva S.A. (IVA)
Precio IVA con Capital del mercado a B
Capitalización de mercado de Inventiva S.A.(IVA)
Capitalización bursátil: $1.12B
A fecha de August 2026, Inventiva S.A. tiene una capitalización de mercado de $1.12B. Esto convierte a Inventiva S.A. en la 8990th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Inventiva S.A. desde 2017 hasta 2026
IVA en comparación con los más populares 5 títulos stocks
| Precio por IVA |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.264T
|
+469,562.19%
|
|
|
|
|
$4.701T
|
+419,365.62%
|
|
|
|
|
$4.177T
|
+372,603.60%
|
|
|
|
|
$3.817T
|
+340,502.96%
|
|
|
|
|
$2.866T
|
+255,645.41%
|
